By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer will sell, service, and provide support for Roche's NimbleGen CGX microarray workflow for most countries outside the US under a supply agreement deal announced today by the two companies.

Roche will continue to sell the workflow in the US and other select markets under the terms of the deal, which takes effect in January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.